Company profile
Atrium Therapeutics, Inc.
NASDAQ:RNABiotechnology: Pharmaceutical Preparations
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT07738107 | phase1_2 | not_yet_recruiting | 2026-10-01 | 2028-05-01 | Atrium Therapeutics | ATR 1072 in Participants With PRKAG2 Syndrome |
FDA applications (0)
No records yet.